<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.neurologylive.com/view/tenecteplase-bridging-therapy-associated-lower-mortality-alteplase-lvo-stroke</loc>
      <lastmod>2026-11-21T20:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-21T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Tenecteplase Bridging Therapy Associated With Lower Mortality Than Alteplase in Large Vessel Occlusion Stroke]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/moving-generalized-myasthenia-gravis-care-beyond-long-term-high-dose-prednisone</loc>
      <lastmod>2026-11-21T16:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-21T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Moving Generalized Myasthenia Gravis Care Beyond Long-Term High-Dose Prednisone]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/fda-approves-2-gmg-treatments-ar1001-slows-decline-monotherapy-group-polaris-ad-trial-benjamin-greenberg-md-mhs-insights-2026-rnds</loc>
      <lastmod>2026-11-21T12:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-21T12:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA Approves 2 gMG Treatments, AR1001 Slows Decline in Monotherapy Group of POLARIS-AD Trial, Benjamin Greenberg's, MD, MHS, Insights From the 2026 RNDS]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/fda-issues-second-complete-response-letter-deramiocel-dmd</loc>
      <lastmod>2026-11-21T01:39:06.554Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-21T01:39:06.554Z</news:publication_date>
        <news:title><![CDATA[FDA Issues Second Complete Response Letter for Deramiocel in Duchenne Muscular Dystrophy]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurologylive-friday-5-november-20-2026</loc>
      <lastmod>2026-11-20T20:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T20:00:00Z</news:publication_date>
        <news:title><![CDATA[NeurologyLive® Friday 5 — November 20, 2026]]></news:title>
        <news:keywords><![CDATA[NeurologyLive Friday 5,Friday 5,NeurologyLive top 5,Neurology top 5,Neurology news top 5,Neurology news,Neurology news updates,top Neurology news]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/rethinking-idiopathic-intracranial-hypertension-as-disorder-arterial-hemodynamics</loc>
      <lastmod>2026-11-20T19:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Rethinking Idiopathic Intracranial Hypertension as a Disorder of Arterial Hemodynamics]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/5-year-clarity-ad-data-sustained-clinical-benefit-lecanemab-early-alzheimer-disease</loc>
      <lastmod>2026-11-20T18:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T18:00:00Z</news:publication_date>
        <news:title><![CDATA[5-Year Clarity AD Data Show Sustained Clinical Benefit With Lecanemab in Early Alzheimer Disease]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/when-does-barth-syndrome-get-worse-stress-the-disease-timeline</loc>
      <lastmod>2026-11-20T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T13:05:00Z</news:publication_date>
        <news:title><![CDATA[When Does Barth Syndrome Get Worse? Stress & the Disease Timeline]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/how-to-diagnose-barth-syndrome-in-2026</loc>
      <lastmod>2026-11-20T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T13:00:00Z</news:publication_date>
        <news:title><![CDATA[How to Diagnose Barth Syndrome in 2026]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/gray-areas-has-traditional-immunotherapy-lost-its-place-myasthenia-gravis</loc>
      <lastmod>2026-11-20T11:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Gray Areas: Has Traditional Immunotherapy Lost Its Place in Myasthenia Gravis?]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/brain-chat-nerve-racking-facial-pain-rare-headaches</loc>
      <lastmod>2026-11-20T11:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Brain Chat: Nerve-Racking Facial Pain and Rare Headaches]]></news:title>
      </news:news>
	</url></urlset>